Abstract:Abstract Background Cancer-related fatigue (CRF) is an extremely common and long-term condition that affects the physical and mental health of oncology patients. While the treatment for CRF with western medicine and non-pharmacological therapy remains uncertain and challenging, traditional Chinese medicine (TCM) has become a trending option for the patients. Based on the findings from randomized controlled trials (RCTs), this study aims to identify and evaluate the evidence about the efficacy and safety of TCM for CRF. Methods A systematic literature search was conducted according to the PRISMA literature research guidelines. Seven electronic databases including PubMed, the Cochrane Library, Embase, Web of Science, Scopus, China National Knowledge Infrastructure (CNKI) and Wanfang database were searched to identify RCTs which investigated TCM in the treatment of CRF published since inception to December 2022. RCTs comparing TCM with no treatment, placebo, or pharmacological interventions were considered eligible for this review. The Consolidated Standards of Reporting Trials Statement extensions for Chinese herbal medicine Formulas (CONSORT-CHM) and the Cochrane Collaboration’s Risk of Bias tool were used in this review to evaluate the quality and the risk of bias of all included trials. Results A total of 82 RCTs were included in this review, regardless of whether they were published in English or Chinese. After data extraction and results evaluation, 78 trials demonstrated overall efficacy in using TCM for CRF patients compared with the control group, in which 33 trials showed that the efficacy rate was statistically significant (p < 0.05 or p < 0.01). TCM was also shown to be beneficial in improving the scores of relevant scales (e.g., PFS, QoL, TCM syndrome score, other fatigue scales etc.) or physical tests indicators (e.g., cytokines, blood test etc.). The most common herbs found in Chinese medicine were Astragali Radix , Ginseng Radix and Codonopsis Radix . Some TCM products, such as Kangai Injection, Buzhong Yiqi Decoction and Shenqi Fuzheng Injection could provide a reference for medication in this review. A range of non-serious, reversible adverse effects associated with the use of TCM was also reported. However, the result of evaluation showed that none of the trials fully met all the CONSORT-CHM criteria, the quality of included trials was generally poor and the risk of bias was mostly uncertain. Conclusion There is some evidence supporting the efficacy and safety of TCM in managing CRF in this systematic review. However, no clear conclusion can be made due to the inadequate reporting of efficacy and adverse reactions. In view of some concerns about the existing evidence after the evaluation, it is essential to standardize the comprehensive identification and efficacy measurement standards, improve the quality of RCTs and conduct more multicomponent therapies to provide an updated reference for CRF patients medication in the future. The protocol of this systematic review has been registered on PROSPERO (CRD42023413625). [ https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023413625 ].

Clinical study on the effect of Shenqifuzheng injection combined with megestrol acetate in improving cancer - related fatigue in patients with advanced cancer

Curative effects of Shenqi Fuzheng injection combined with megestrol acetate dispersable tablets intreatment of advanced cancer

Influence of megestrol acetate dispersable tablets combined with Shenqi Fuzheng injection on quality of life in advanced cancer patients

Effect of Traditional Chinese Medicine Injection on Cancer-Related Fatigue: A Meta-Analysis Based on Existing Evidence

Meta Analysis of Treatting Cancer Related Fatigue with the Traditional Chinese Medicine of Supplementing Qi Combined with Chemotherapy

Ef ect of Shenqi -fuzheng injection combined with Gemcitabine chemotherapy in the treatment of advanced non -smal cel lung cancer

Clinical evidence-based research on Shenqifuzheng injection with chemotherapy in treatment of advanced gastric carcinoma

Jianpi Fuzheng Decoction in the Treatment of Gastric Cancer-Related Fatigue

Shenmai injection for the treatment of cancer-related fatigue in advanced non-small cell lung cancer patients undergoing chemotherapy: study protocol for a randomized controlled trial

The Effect Of Shenqi Fuzheng Injection In Combination With Chemotherapy Versus Chemotherapy Alone On The Improvement Of Efficacy And Immune Function In Patients With Advanced Non-Small Cell Lung Cancer: A Meta-Analysis

Evaluation of Adjunct Efftct on Shenqi Fuzheng Injection Tumor Chemotherapy

Clinical Effects of Shenqi Fuzheng Injection in the Neoadjuvant Chemotherapy for Local Advanced Breast Cancer and the Effects on T-lymphocyte Subsets.

Clinical study of shenqi fuzheng injection decreasing side-effects of tp chemotherapy for patients with gynecological malignant tumor

Influence of Shenqi Fuzheng injection combined with radio-chemotherapy on quality of life in head and neck cancer patients

Analysis on the effect of Shenqi Fuzheng Injection combined with FolFox4 regimen versus FolFox4 regimen alone in patients with advanced gastric cancer

Effectiveness and Safety of Traditional Chinese Medicine Injection Combined with CF Chemotherapy Regimen in the Treatment of Breast Cancer:Network Meta-analysis and Trial Sequential Analysis

Ren Shen Yangrong Tang for Fatigue in Cancer Survivors: A Phase I/II Open-Label Study.

Efficacy of Ginseng-Based Renshenguben Oral Solution for Cancer-Related Fatigue among Patients with Advanced-Stage Hepatocellular Carcinoma: A Prospective Multicenter Cohort Study.

Efficacy and safety of traditional Chinese medicine for cancer-related fatigue: a systematic literature review of randomized controlled trials

Shenqi Fuzheng Injection for advanced gastric cancer: a systematic review of randomized controlled trials.

Clinical observation of efficacy and adverse reactions on Shenqifuzheng injection used in patients with breast cancer receiving neoadjuvant chemotherapy